Pronociceptive actions of dynorphin via bradykinin receptors
Lai J, Luo MC, Chen Q, Porreca F.
Department of Pharmacology,
University of Arizona Health Sciences Center,
1501 N. Campbell Avenue,
Tucson, AZ 85724, USA.
Neurosci Lett. 2008 Apr 8
ABSTRACTThe endogenous opioid peptide dynorphin A is distinct from other endogenous opioid peptides in having significant neuronal excitatory and neurotoxic effects that are not mediated by opioid receptors. Some of these non-opioid actions of dynorphin contribute to the development of abnormal pain resulting from a number of pathological conditions. Identifying the mechanisms and the sites of action of dynorphin is essential for understanding the pathophysiology of dynorphin and for exploring novel therapeutic targets for pain. This review will discuss the mechanisms that have been proposed and the recent finding that spinal dynorphin may be an endogenous ligand of bradykinin receptors under pathological conditions to promote pain.
Dynorphin and depression
Dynorphin, dopamine and CART
Kappa receptors, dopamine d3, and cocaine
Dynorphin: Nature's own antidote to cocaine?
and further reading
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World
The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family